We use cookies to provide you with a better experience. By continuing to browse the site you are agreeing to our use of cookies in accordance with our Cookie Policy.
Accept
Home » Federal Court Invalidates One of Two Amifostine Patents
Federal Court Invalidates One of Two Amifostine Patents
January 23, 2007
A federal court invalidated one of two patents challenged by Sun Pharmaceuticals to market amifostine, a generic version of MedImmune Oncology’s dry mouth treatment drug, Ethyol.